Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Connolly currently holds 20,473 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Connolly has been a net seller of VRTX stock. They have purchased $5.2M and sold $226.0M worth of shares.
Thomas Connolly's most recent insider trade was on Dec 17, 2025, when they sold 1,041 shares at $25.23 per share.
Thomas Connolly serves as Executive at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have executed 101 insider transactions totaling $231.3M over their tenure at the company.
Thomas Connolly holds the position of Executive at VERTEX PHARMACEUTICALS INC / MA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Thomas Connolly has shown a selling trading pattern, with $5.2M in total purchases and $226.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Connolly was on May 26, 2020, when they sold $218.2M worth of AVTR shares. This transaction involved 13,726,411 shares at $15.90 per share.
Thomas Connolly currently owns 20,473 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Connolly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Connolly has 101 Form 4 filings on record as an insider at VERTEX PHARMACEUTICALS INC / MA.
Set alerts for Thomas Connolly and 40,000+ other insiders.